NCT07294066 2026-04-15
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
UNC Lineberger Comprehensive Cancer Center
Phase NA Not yet recruiting
Clinical Trials
280 trialsNCT07521163 2026-04-15
HBM-HPV
Yuzuncu Yil University
Phase NA Not yet recruiting
NCT07530133 2026-04-15
Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
Phase NA Not yet recruiting
NCT07530679 2026-04-15
Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination
Jiangsu Province Centers for Disease Control and Prevention
Phase NA Not yet recruiting
NCT07532148 2026-04-15
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Chong Kun Dang Pharmaceutical
Phase 1 Not yet recruiting
NCT07349641 2026-04-13
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT07504588 2026-04-13
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT07522697 2026-04-13
MITO END-4
National Cancer Institute, Naples
Phase 2 Not yet recruiting
NCT07523152 2026-04-13
SAPPHIRE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Not yet recruiting
NCT07524322 2026-04-13
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Phase 1 Not yet recruiting
NCT07189702 2026-04-08
BEND-MBEC
University of Rochester
Phase NA Not yet recruiting
NCT07495124 2026-04-08
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
University of Washington
Phase 2 Not yet recruiting
NCT07514078 2026-04-07
Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer
Ain Shams Maternity Hospital
Phase NA Not yet recruiting
NCT07514325 2026-04-07
MASTEC
Radboud University Medical Center
Phase NA Not yet recruiting
NCT07516210 2026-04-07
ART-Hypo
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Not yet recruiting
NCT07503054 2026-03-31
AI-OCS-Gyn
Charite University, Berlin, Germany
Phase NA Not yet recruiting
NCT07090109 2026-03-30
PITCH - Impacting Hereditary Cancer Testing
University of Kentucky
Phase NA Not yet recruiting
NCT06872346 2026-03-27
PREDICT
Massachusetts General Hospital
Phase NA Not yet recruiting
NCT07383506 2026-03-27
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Cogent Biosciences, Inc.
Phase 1 Not yet recruiting
NCT07489287 2026-03-27
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
Roswell Park Cancer Institute
Phase 1 Not yet recruiting
NCT07497074 2026-03-27
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Not yet recruiting
NCT06476639 2026-03-24
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting
NCT07256912 2026-03-24
CervALONE
International Agency for Research on Cancer
Phase 4 Not yet recruiting
NCT07489300 2026-03-24
BACON
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT06834204 2026-03-23
ACCESS-PC
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07487168 2026-03-23
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Not yet recruiting
NCT07286266 2026-03-19
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
GlaxoSmithKline
Phase 3 Not yet recruiting
NCT06726330 2026-03-17
FIMBRIMENOP
Centre Oscar Lambret
Phase NA Not yet recruiting
NCT05479045 2026-03-16
A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
Georgetown University
Phase 2 Not yet recruiting
NCT07455071 2026-03-16
YS247
Peking University Third Hospital
Phase NA Not yet recruiting
NCT05521997 2026-03-13
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT07462468 2026-03-13
A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
WestVac Biopharma Co., Ltd.
Phase 1 Not yet recruiting
NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
NCT07466901 2026-03-12
A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
Fudan University
Phase NA Not yet recruiting
NCT07467772 2026-03-12
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
NCT07468695 2026-03-12
Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07286331 2026-03-11
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)
GlaxoSmithKline
Phase 3 Not yet recruiting
NCT04520139 2026-03-10
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
University of California, Irvine
Phase 1/2 Not yet recruiting
NCT07461064 2026-03-10
HIFU Colpo
Queen Mary Hospital, Hong Kong
Phase NA Not yet recruiting
NCT07461142 2026-03-10
RETHEMCOL
Institut Paoli-Calmettes
Phase NA Not yet recruiting
NCT06850402 2026-03-09
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07454915 2026-03-09
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
PapiVax Biotech, Inc.
Phase 2 Not yet recruiting
NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07453459 2026-03-06
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07454018 2026-03-06
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
The First Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT07450963 2026-03-05
Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07429071 2026-03-04
Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.
University of Aarhus
Phase EARLY_PHASE1 Not yet recruiting
NCT07447895 2026-03-04
Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
University of Cincinnati
Phase NA Not yet recruiting
NCT07446049 2026-03-03
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Phase 2 Not yet recruiting
NCT07435987 2026-02-27
ARCHITECT
Erasmus Medical Center
Phase NA Not yet recruiting